Market Cap | ₹155Cr |
ROE | 18.42% |
P/E Ratio(TTM) | -5.72 |
EPS(TTM) | -12.57 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 39.58 |
Book Value | -67.83 |
Debt to Equity | -1.45 |
Face Value | 10 |
Parent Organisation | Krebs Biochemicals And Industries |
Managing Director | Mr. Pabitra Bhattacharya |
NSE Symbol | KREBSBIO |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 67.54 | ||
Neuland Laboratories | NA (0.00%) | 110.79 | ||
Jubilant Pharmova | NA (0.00%) | 38.77 | ||
Acutaas Chemicals | NA (0.00%) | 59.57 |